1-METHYLCYCLOHEX-3-ENECARBOXYLIC ACID, 95.0%, 250mg

2,3,5-Trifluorocinnamic acid, 1g

N-(4-Iodophenyl)-4-methylbenzenesulfonamide, 97%, 5g

4-Methyl-2-(methylthio)pyrimidine-5-carbaldehyde, 95%, 1g

8-Bromo-4-chloro-7-methoxy-1,6-naphthyridine, 95.0%, 5g

(1S)-5-FLUORO-1,2,3,4-TETRAHYDRONAPHTHYLAMINE, 95.0%, 1g

4-(3,4-Dichloro-benzoylamino)-1-methyl-1H-pyrrole--2-carboxylic acid, 98%, 25g

4-BROMOTHIOPHEN-3-AMINE HCL, 95.0%, 100mg

Methyl 4,5-dibromo-3-fluorothiophene-2-carboxylate, 95+%, 500mg

BenzaMide, N-[[tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]Methyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]-, 100mg

(R)-Cyclohexylhydroxyphenylacetic acid, 95.0%, 100mg

Colonna capillare per GC ROTI®Cap-5 MS, 25 m, 0.32 mm, 1.00 µm, 1 Pezzo(i)

4'-Carboxybenzo-15-crown 5-Ether>98.0%(GC)(T)1g